A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GCB / gemcitabine

[Related PubMed/MEDLINE]
Total Number of Papers: 31
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GCB  (>> Co-occurring Abbreviation)
Long Form:   gemcitabine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells. 5-FU
2021 Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters. EA, EMT
2021 Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. OA, PCa
2021 Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy. 5-FC, DOX, GCV, MSC, PTX, TRAIL
2020 The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases. FasL, OS
2019 MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin. BCa, EPB, miRNA
2019 The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. ABC, dCK, T24-GCB, TK
2018 Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing. OS
2018 Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy. OS, pHSP27
10  2018 Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation. ---
11  2018 Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities. TQ
12  2017 Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. CLVA, EBV, GCV, NPC, VPA
13  2017 Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. DXR, MSCs, PTX
14  2015 Gemcitabine-releasing mesenchymal stromal cells inhibit invitro proliferation of human pancreatic carcinoma cells. MSCs, pCa
15  2014 Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment. PDAC, RF
16  2014 Autophagy in osteosarcoma. OS
17  2014 Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway. HCC, sCLU
18  2014 Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases. ---
19  2014 Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression. BA, CI, PK, TQ
20  2012 Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors. CLVA, EBV, GCV, NPC, VPA
21  2011 Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. ---
22  2010 Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. FDN, OS
23  2008 Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma. ---
24  2006 Toxicity and efficacy of isolated lung perfusion with gemcitabine in a rat model of pulmonary metastases. i.v, ILuP
25  2005 Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. OS
26  2004 Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study. CHT, mos, NSCLC, pts
27  2003 Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. ILuP
28  2003 Pharmacokinetics after pulmonary artery perfusion with gemcitabine. BFO, i.v, ILuP
29  2003 Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report. RCC, SCLS
30  2002 Gemcitabine-induced systemic capillary leak syndrome. SCLS
31  2001 Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study. PD, SD